Synthesis and in vitro biological evaluation of novel dendrocandin analogue as potential anti-tumor agent

Nat Prod Res. 2022 Aug;36(15):3951-3956. doi: 10.1080/14786419.2021.1901698. Epub 2021 Mar 22.

Abstract

Dendrocandins are characteristic chemical structures of D. officinale and have strong physiological bioactivities. In this study, a dendrocandin analogue (1) has been prepared by total synthesis (9 steps, 12.6% overall yield) in which coupling reaction and Wittig reaction as the key steps. Compound 1 was also evaluated for its anticancer activity in vitro against six human cancer cells (MCF-7, A549, A431, SW480, HepG-2 and HL-60) using MTT assays. Compound 1 showed potent cytotoxicity, with the IC50 value 16.27 ± 0.26 µM. The expression levels of apoptotic proteins indicated that compound 1 can up-regulate the expression of apoptotic proteins, leading to apoptosis. This compound suggested that it's potential as anticancer agent for further development.

Keywords: Dendrocandin analogue; anticancer activity; apoptosis; synthesis.

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Apoptosis
  • Cell Line, Tumor
  • Cell Proliferation
  • Drug Screening Assays, Antitumor
  • Humans
  • Molecular Structure
  • Neoplasms*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents